Stay updated on Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.

Latest updates to the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page
- Check3 days agoChange DetectedThe page’s displayed application/revision indicator is updated from v3.5.2 to v3.5.3, reflecting a backend/UI version bump rather than a change to the clinical trial record.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision history now includes Revision: v3.5.2; Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision v3.5.0 was added and Revision v3.4.3 was removed from the record history. This updates the page’s version log to reflect the latest changes.SummaryDifference0.1%

- Check46 days agoChange DetectedNew history entry added for Revision v3.4.3 with a Study Status update, and the previous Revision v3.4.2 entry (dated 2025-11-20) was removed.SummaryDifference0.4%

- Check74 days agoChange DetectedAdded Revision: v3.4.2 to the history; removed the Notice about lapse in government funding and Revision: v3.4.1.SummaryDifference0.6%

- Check82 days agoChange DetectedAdded a government funding notice and the latest revision entry (v3.4.1); removed the previous revision entry (v3.4.0) from the history.SummaryDifference0.6%

Stay in the know with updates to Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.